参考文献/References:
[1] Bogana Shanmugam V,Psaltis PJ,Tay L,et al. Procedural and clinical outcomes in management of bifurcational lesions in ST elevation myocardial infarction[J]. Heart Lung Circ,2020,29(2):272-279.
[2] Zhang JJ,Ye F,Xu K,et al. Multicentre,randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions:the DEFINITION Ⅱ trial[J]. Eur Heart J,2020,41(27): 2523-2536.
[3] Colombo A,Leone PP. Treating bifurcation lesions:the result overcomes the technique[J].JACC Cardiovasc Interv,2021,14(21):2327-2329.
[4] 谢恩睿,刘畅,倪雅娟,等. 药物涂层球囊对比普通球囊治疗冠状动脉原发分叉病变疗效的荟萃分析[J]. 中华心血管病杂志,2021,49(12):1227-1234.
[5] Wassef AWA,Liu S,Yanagawa B,et al. Percutaneous management of coronary bifurcation lesions:current perspective[J]. Curr Opin Cardiol,2020,35(5):574-582.
[6] Elwany M,Palma GD,Cortese B. Treatment of coronary bifurcation lesions:current knowledge and future perspectives[J]. Future Cardiol,2018,14(2): 165-179.
[7] Tan S,Ramzy J,Burgess S,et al. Percutaneous coronary intervention for coronary bifurcation lesions:latest evidence[J]. Curr Treat Options Cardiovasc Med,2020,22(2):6.
[8] Chen SL,Sheiban I,Xu B,et al. Impact of the complexity of bifurcation lesions treated with drug-eluting stents:the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts)[J]. JACC Cardiovasc Interv,2014,7(11):1266-1276.
[9] Chen SL,Zhang JJ,Han Y,et al. Double kissing crush versus provisional stenting for left main distal bifurcation lesions:DKCRUSH-Ⅴ randomized trial[J]. J Am Coll Cardiol,2017,70(21):2605-2617.
[10] Cortese B,Buccheri D,Piraino D,et al. Drug-coated balloon angioplasty for coronary chronic total occlusions. An OCT analysis for a "new" intriguing strategy[J]. Int J Cardiol,2015,189:257-258.
[11] Hildick-Smith D,Behan MW,Lassen JF,et al. The EBC TWO Study (European Bifurcation Coronary TWO) a randomized comparison of provisional T-stenting versus a systematic 2 stent culotte strategy in large caliber true bifurcations[J]. Circ Cardiovasc Interv,2016,9(9):e003643.
[12] Hildick-Smith D,Egred M,Banning A,et al. The European bifurcation club left main coronary stent study:a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)[J]. Eur Heart J,2021,42(37):3829-3839.
[13] Chiabrando JG,Lombardi M,Vescovo GM,et al. Stenting techniques for coronary bifurcation lesions:evidence from a network meta-analysis of randomized clinical trials[J]. Catheter Cardiovasc Interv,2021,97(3):E306-E318.
[14] Di Gioia G,Sonck J,Ferenc M,et al. Clinical outcomes following coronary bifurcation PCI techniques:a systematic review and network meta-analysis comprising 5,711 patients[J]. JACC Cardiovasc Interv,2020,13(12):1432-1444.
[15] Burzotta F,Lassen J,Lefèvre T,et al. Percutaneous coronary intervention for bifurcation coronary lesions:the 15th consensus document from the European Bifurcation Club[J].EuroIntervention,2021,16(16):1307-1317.
[16] 陈良龙,陈绍良. 冠状动脉分叉病变介入治疗简明教程:优化型必要时T支架术[M]. 北京:人民军医出版社.2016;40-49.
[17] Corballis NH,Paddock S,Gunawardena T,et al. Drug coated balloons for coronary artery bifurcation lesions:a systematic review and focused meta-analysis[J]. PLoS One,2021,16(7):e0251986.
[18] Jing QM,Zhao X,Han YL,et al. A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch:a prospective multicenter ranDomized (BEYOND) clinical trial in China[J]. Chin Med J(Engl),2020,133(8):899-908.
[19] López Mínguez JR,Nogales Asensio JM,Doncel Vecino LJ,et al. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial):24-month clinical and angiographic results[J]. EuroIntervention,2014,10(1):50-57.
[20] Stella PR,Belkacemi A,Dubois C,et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique:six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial[J]. Catheter Cardiovasc Interv,2012,80(7):1138-1146.
[21] Desilvey DL. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter[J]. Am J Geriatr Cardiol,2007,16(2):115-116.
[22] Meredith I,Worthley S,Walters DL,et al. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations:12-month results of the multicenter BIOLUX-Ⅰ study[J]. Cardiovasc Revasc Med,2015,16(7):413-417.
[23] Schulz A,Hauschild T,Kleber FX. Treatment of coronary de novo bifurcation lesions with DCB only strategy[J]. Clin Res Cardiol,2014,103(6):451-456.
[24] Mathey DG,Wendig I,Boxberger M,et al. Treatment of bifurcation lesions with a drug-eluting balloon:the PEPCAD Ⅴ (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial[J]. EuroIntervention,2011,7(suppl K):K61-K65.
[25] Kleber FX,Rittger H,Ludwig J,et al. Drug eluting balloons as stand alone procedure for coronary bifurcational lesions:results of the randomized multicenter PEPCAD-BIF trial[J]. Clin Res Cardiol,2016,105(7):613-621.
[26] Kleber FX,Mathey DG,Rittger H,et al. How to use the drug-eluting balloon:recommendations by the German consensus group[J]. EuroIntervention,2011,7(suppl K):K125-K128.
相似文献/References:
[1]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[2]贺彩红 荣晶晶 潘宏伟.定量血流分数在急性心肌梗死中的应用进展[J].心血管病学进展,2021,(4):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
HE Caihong,RONG Jingjing,PAN Hongwei.Progress in the Application of Quantitative Flow Ratio in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(6):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
[3]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(6):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[4]梁晨笛 秦纲.经皮冠状动脉介入诊疗中穿刺路径研究进展[J].心血管病学进展,2022,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
LIANG Chendi,QIN Gang.Puncture Routes in Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(6):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(6):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[6]张爽 吴娜琼.腔内影像学在冠状动脉支架内再狭窄诊治应用中的研究进展[J].心血管病学进展,2022,(5):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
ZHANG Shuang,WU Na qiong.Application of Intravascular Imaging in Diagnosis and Treatment of Coronary In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(6):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
[7]管翔 王宇 张成糕 周健 张艺 李庆国.经皮心室辅助装置在复杂高危冠状动脉介入治疗中的应用进展[J].心血管病学进展,2022,(5):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
GUAN Xiang,WANG Yu,ZHANG Chenggao,et al.Application Progress of Percutaneous Ventricular Assist Device in Complex High-Risk Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(6):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
[8]宋艳华 来春林 杨五小.急性 ST段抬高型心肌梗死患者微血管功能障碍的研究进展[J].心血管病学进展,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
SONG Yanhua,LAI Chunlin,YANG Wuxiao.Microvascular Dysfunction in Patients with Acute ST-Segment?levation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
[9]纪欣强 王凡.肥胖悖论与经皮冠状动脉介入治疗预后相关性的研究进展[J].心血管病学进展,2022,(7):615.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
JI XinqiangWANG Fan.Correlation Between Obesity Paradox and Prognosis of Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(6):615.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[10]王兰 叶玉兰 宁明安 张迪 尚粉青.血清PCSK9水平与PCI后冠状动脉病变再进展的关系研究[J].心血管病学进展,2022,(7):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
WANG Lan,YE Yulan,NING Mingan,et al.Correlation Analysis Between Serum PCSK9 Level and Coronary Artery Pathological ?Progression After PCI[J].Advances in Cardiovascular Diseases,2022,(6):667.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]